Tetrafunctional Block Copolymers Promote Lung Gene Transfer in Newborn Piglets.

gene therapy lungs newborn pigs non-viral vector tetrafunctional block copolymers

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
07 Jun 2019
Historique:
received: 04 12 2018
revised: 15 02 2019
accepted: 15 02 2019
pubmed: 22 3 2019
medline: 22 3 2019
entrez: 22 3 2019
Statut: ppublish

Résumé

Tetrafunctional block copolymers are molecules capable of complexing DNA. Although ineffective in vitro, studies in mice have shown that the tetrafunctional block copolymer 704 is a more efficient lung gene transfer agent than the cationic liposome GL67A, previously used in a phase II clinical trial in cystic fibrosis patients. In the present study, we compared the gene transfer capacity of the 704-DNA formulation and a cationic liposome-DNA formulation equivalent to GL67A in a larger-animal model, the newborn piglet. Our results indicate an efficacy of the 704-DNA formulation well above one order of magnitude higher than that of the cationic liposome-DNA formulation, with no elevated levels of interleukin-6 (IL-6), taken as a marker of inflammation. Transgene expression was heterogeneous within lung lobes, with expression levels that were below the detection threshold in some samples, while high in other samples. This heterogeneity is likely to be due to the bolus injection procedure as well as to the small volume of injection. The present study highlights the potential of tetrafunctional block copolymers as non-viral vectors for lung gene therapy.

Identifiants

pubmed: 30897407
pii: S2162-2531(19)30046-0
doi: 10.1016/j.omtn.2019.02.016
pmc: PMC6426709
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

186-193

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Nucleic Acids Res. 2011 Mar;39(4):1595-609
pubmed: 21078679
Biomaterials. 2018 Mar;159:189-203
pubmed: 29331806
Lancet. 1999 Mar 20;353(9157):947-54
pubmed: 10459902
Infect Immun. 2016 Sep 19;84(10):2895-903
pubmed: 27481243
Nucleic Acids Res. 2013 Nov;41(20):e192
pubmed: 24013565
Lancet Respir Med. 2015 Sep;3(9):684-691
pubmed: 26149841
Mol Ther Nucleic Acids. 2015 Jun 23;4:e244
pubmed: 26102064
Nucleic Acids Res. 2004 Nov 16;32(20):e159
pubmed: 15547248
Mol Ther. 2010 Jun;18(6):1173-82
pubmed: 20332767
J Gene Med. 2005 Jan;7(1):80-6
pubmed: 15468192
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14412-7
pubmed: 9405626
Mol Ther. 2006 Aug;14(2):183-91
pubmed: 16581299
Mol Genet Genomics. 2013 Aug;288(7-8):347-63
pubmed: 23743652
PLoS One. 2014 Jan 31;9(1):e85976
pubmed: 24497934
Adv Drug Deliv Rev. 2009 Feb 27;61(2):128-39
pubmed: 19138713
PLoS One. 2011;6(12):e28842
pubmed: 22205974
PLoS One. 2016 Dec 16;11(12):e0168577
pubmed: 27992534
Hum Gene Ther. 2012 Jun;23(6):597-608
pubmed: 22429072
J Clin Invest. 2007 Apr;117(4):1008-18
pubmed: 17347683
Hum Gene Ther. 2005 Nov;16(11):1318-24
pubmed: 16259565
Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):147-70
pubmed: 19056129
J Hepatol. 2011 Jan;54(1):115-21
pubmed: 20961645
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16534-9
pubmed: 17923669
Anim Sci J. 2016 Dec;87(12):1511-1515
pubmed: 26990379
Thorax. 2017 Feb;72(2):137-147
pubmed: 27852956
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2621-6
pubmed: 10077560
Biomaterials. 2015 Mar;45:10-7
pubmed: 25662490
Trends Immunol. 2012 Nov;33(11):571-7
pubmed: 22883707
Nucleic Acids Res. 2011 Mar;39(4):1610-22
pubmed: 20952409
Mol Ther. 2002 Feb;5(2):98-103
pubmed: 11829516
J Gene Med. 2014 Sep-Oct;16(9-10):291-9
pubmed: 25130650
Sci Transl Med. 2011 Mar 16;3(74):74ra24
pubmed: 21411740
Hum Gene Ther. 2005 Jul;16(7):821-9
pubmed: 16000064
Mol Ther. 2008 Dec;16(12):1937-43
pubmed: 18813278
J Virol. 2005 Oct;79(20):12818-27
pubmed: 16188984
Am J Respir Crit Care Med. 2012 Nov 1;186(9):846-56
pubmed: 22955314
Gene Ther. 2018 Aug;25(5):345-358
pubmed: 30022127
Gene Ther. 2012 Jan;19(1):94-100
pubmed: 21633394
Lab Chip. 2009 Aug 7;9(15):2184-93
pubmed: 19606295
N Engl J Med. 2015 Jan 22;372(4):351-62
pubmed: 25607428
Vaccine. 2018 Nov 12;36(46):6911-6917
pubmed: 30337177
Vaccine. 2015 Apr 27;33(18):2118-24
pubmed: 25804706
Mol Ther. 2000 Feb;1(2):180-8
pubmed: 10933929
Nucleic Acids Res. 2007;35(3):728-39
pubmed: 17182627
Hum Gene Ther. 2008 Apr;19(4):331-42
pubmed: 18341422
Hum Gene Ther Clin Dev. 2014 Jun;25(2):97-107
pubmed: 24865497
J Clin Invest. 2002 Aug;110(4):499-504
pubmed: 12189244
Expert Opin Biol Ther. 2013 Mar;13(3):345-60
pubmed: 23289747
Respir Res. 2014 May 20;15:60
pubmed: 24884387
J Virol. 2003 Feb;77(4):2607-14
pubmed: 12551999
J Control Release. 2012 Mar 28;158(3):461-9
pubmed: 22226775
Hum Gene Ther. 2002 Sep 20;13(14):1767-75
pubmed: 12396628
Hum Gene Ther. 1994 Oct;5(10):1259-77
pubmed: 7531503
Biomaterials. 2013 Dec;34(38):10267-77
pubmed: 24090839
Sci Transl Med. 2010 Apr 28;2(29):29ra31
pubmed: 20427821
Curr Opin Pharmacol. 2017 Jun;34:119-124
pubmed: 29107808
Cancer Gene Ther. 2011 Nov;18(11):761-72
pubmed: 21869819
Gene Ther. 2014 Jan;21(1):89-95
pubmed: 24196086
Am J Respir Crit Care Med. 2013 Dec 15;188(12):1434-41
pubmed: 24168209
Gene Ther. 2011 Oct;18(10):996-1005
pubmed: 21512505
Cancer Res. 2009 Mar 15;69(6):2655-62
pubmed: 19258509

Auteurs

Ignacio Caballero (I)

INRA Centre Val de Loire - Université de Tours, UMR-1282 Infectiologie et Santé Publique (ISP), 37380 Nouzilly, France.

Mickaël Riou (M)

INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), 37380 Nouzilly, France.

Océane Hacquin (O)

Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France.

Claire Chevaleyre (C)

INRA Centre Val de Loire - Université de Tours, UMR-1282 Infectiologie et Santé Publique (ISP), 37380 Nouzilly, France.

Céline Barc (C)

INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), 37380 Nouzilly, France.

Jérémy Pezant (J)

INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), 37380 Nouzilly, France.

Anne Pinard (A)

INRA Centre Val de Loire, UE-1277 Plateforme d'Infectiologie expérimentale (PFIE), 37380 Nouzilly, France.

Julien Fassy (J)

Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France.

Roger Rezzonico (R)

Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France.

Bernard Mari (B)

Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France.

Nathalie Heuzé-Vourc'h (N)

Centre d'Etude des Pathologies Respiratoires, U1100, INSERM, Tours, France.

Bruno Pitard (B)

CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.

Georges Vassaux (G)

Université Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France; FHU-OncoAge, Nice, France. Electronic address: vassaux@ipmc.cnrs.fr.

Classifications MeSH